Azitra, Inc. (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative therapies for ...
CereVasc, Inc., a clinical-stage medical device company developing novel treatments for neurological diseases, today ...
LIXTE Biotechnology Holdings (NASDAQ: LIXT) announced an expansion of its collaboration with The University of Texas MD ...
Spartan Medical® and SI-BONE® announce new partnership to expand access to advanced ultra–minimally invasive treatment ...
Over the past year, RenovoRx has Tripled Commercially Active U.S. Cancer Centers and Centers Requesting Access to RenovoCath, its FDA-Cleared ...
Tidewave Bio, a biotechnology company developing a universal, biopsy-native immunotherapy platform for solid tumors, today announced the appointment of Prof. Alexander M.M.
AIM ImmunoTech Inc. (NYSE American: AIM) ("AIM" or the "Company") today announced milestones in the expected timeline for the ongoing Phase 2 clinical study ...
Q4 2026 Earnings Call February 25, 2026 9:00 AM ESTCompany ParticipantsKate Pearlman - Vice President, Investor Relations ...
TARA-002 was developed from the same master cell bank of genetically distinct group A Streptococcus pyogenes as OK-432, a broad immunopotentiator marketed as Picibanil® in Japan by Chugai ...
Q4 2025 Earnings Call February 26, 2026 9:00 AM ESTCompany ParticipantsGordon Johnston - President, CEO & Non- ...
Recently Nasdaq-Listed Company Introduces Longevity Blood Test Integrating Inflammatory Biomarkers, Dietary Habits, and Curated Scientific Research to Deliver Personalized Health Insights GAITHERSBURG ...
Lowe’s Companies, Inc. (NYSE:LOW) Q4 2026 Earnings Call Transcript February 25, 2026 Lowe’s Companies, Inc. beats earnings expectations. Reported EPS is $1.98, expectations were $1.94. Operator: Good ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results